The DOI matches its Crossref record; 65 of the 65 references it cites were found in a registry or an index.
Mechanisms of Cytomegalovirus-Accelerated Vascular Disease: Induction of Paracrine Factors That Promote Angiogenesis and Wound Healing
Open accessAbstract
Human cytomegalovirus (HCMV) is associated with the acceleration of a number of vascular diseases such as atherosclerosis, restenosis, and transplant vascular sclerosis (TVS). All of these diseases are the result of either mechanical or immune-mediated injury followed by inflammation and subsequent smooth muscle cell (SMC) migration from the vessel media to the intima and proliferation that culminates in vessel narrowing. A number of epidemiological and animal studies have demonstrated that CMV significantly accelerates TVS and chronic rejection (CR) in solid organ allografts. In addition, treatment of human recipients and animals alike with the antiviral drug ganciclovir results in prolonged survival of the allograft, indicating that CMV replication is a requirement for acceleration of disease. However, although virus persists in the allograft throughout the course of disease, the number of directly infected cells does not account for the global effects that the virus has on the acceleration of TVS and CR. Recent investigations of up- and downregulated cellular genes in infected allografts in comparison to native heart has demonstrated that rat CMV (RCMV) upregulates genes involved in wound healing (WH) and angiogenesis (AG). Consistent with this result, we have found that supernatants from HCMV-infected cells (HCMV secretome) induce WH and AG using in vitro models. Taken together, these findings suggest that one mechanism for HCMV acceleration of TVS is mediated through induction of secreted cytokines and growth factors from virus-infected cells that promote WH and AG in the allograft, resulting in the acceleration of TVS. We review here the ability of CMV infection to alter the local environment by producing cellular factors that act in a paracrine fashion to enhance WH and AG processes associated with the development of vascular disease, which accelerates chronic allograft rejection.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Considering recent evidence implicating angiogenesis in HCMV-associated vasculopathies (128), Dumortier et al. (124) profiled the secretome of HCMV-infected human dermal fibroblasts.”
From The Impact of Mass Spectrometry–Based Proteomics on Fundamental Discoveries in Virology (2014) · cites this paper as [128]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
J Heart Lung Transplant 2021;40(4).
(2021) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2021.04.002 · Cited by 6,824
Angiogenesis in health and disease
Carmeliet, P. (2003) · Nature Medicine · doi:10.1038/nm0603-653 · Cited by 4,379
Regulation of Wound Healing by Growth Factors and Cytokines
WERNER, S., & GROSE, R. (2003) · Physiological Reviews · doi:10.1152/physrev.2003.83.3.835 · Cited by 3,629
Cytomegalovirus Infection Is Associated With Cardiac Allograft Rejection and Atherosclerosis
Grattan, M. T. (1989) · JAMA · doi:10.1001/jama.1989.03420240075030 · Cited by 966
Wegener, J., Keese, C. R., & Giæver, I. (2000) · Experimental Cell Research · doi:10.1006/excr.2000.4919 · Cited by 773
Potential Role of Human Cytomegalovirus and p53 Interaction in Coronary Restenosis
Speir, E. H., Modali, R., Huang, E., Leon, M. B., Shawl, F. A., Finkel, T., & Epstein, S. E. (1994) · Science · doi:10.1126/science.8023160 · Cited by 753
Angiogenesis Assays: A Critical Overview
Auerbach, R., Lewis, R. L., Shinners, B., Kubai, L., & Akhtar, N. (2003) · Clinical Chemistry · doi:10.1373/49.1.32 · Cited by 705
Fundamental Concepts of the Angiogenic Process
Folkman, J. (2003) · Current Molecular Medicine · doi:10.2174/1566524033479465 · Cited by 666
The Human Cytomegalovirus Chemokine Receptor US28 Mediates Vascular Smooth Muscle Cell Migration
Streblow, D. N., Söderberg‐Nauclér, C., Vieira, J., Smith, P., Wakabayashi, E., Ruchti, F., Mattison, K., Altschuler, Y., & Nelson, J. A. (1999) · Cell · doi:10.1016/s0092-8674(00)81539-1 · Cited by 439
Self-citationElectrical wound-healing assay for cells in vitro
Keese, C. R., Wegener, J., Walker, S. R., & Giæver, I. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0307588100 · Cited by 423
A Controlled Trial of Ganciclovir to Prevent Cytomegalovirus Disease after Heart Transplantation
Merigan, T. C., Renlund, D. G., Keay, S., Bristow, M. R., Starnes, V., O'Connell, J. B., Resta, S., Dunn, D., Gamberg, P., Ratkovec, R. M., et al. (1992) · New England Journal of Medicine · doi:10.1056/nejm199204303261803 · Cited by 376
CYTOMEGALOVIRUS ANTIGEN WITHIN HUMAN ARTERIAL SMOOTH MUSCLE CELLS
Melnick, J. L. (1983) · The Lancet · doi:10.1016/s0140-6736(83)92529-1 · Cited by 332
Valantine, H. A., Gao, S., Menon, S. G., Renlund, D. G., Hunt, S. A., Oyer, P. E., Stinson, E. B., Brown, B. W., Merigan, T. C., & Schroeder, J. S. (1999) · Circulation · doi:10.1161/01.cir.100.1.61 · Cited by 291
Histopathology of graft coronary disease.
Billingham, M. E. (1992) · PubMed · Cited by 249
Cardiac allograft vasculopathy: current concepts, recent developments, and future directions.
Hosenpud, J. D., Shipley, G. D., & Wagner, C. R. (1992) · PubMed · Cited by 218
Cytokines and growth factors in atherogenesis.
Clinton, S. K., & Libby, P. (1992) · PubMed · Cited by 183
Mckie, D. (1974) · The Lancet · doi:10.1016/s0140-6736(74)91959-x · Cited by 170
A review on pro- and anti-angiogenic factors as targets of clinical intervention
Bouïs, D., Kusumanto, Y. H., MEIJER, C., MULDER, N., & Hospers, G. A. P. (2005) · Pharmacological Research · doi:10.1016/j.phrs.2005.10.006 · Cited by 166
Lemström, K., BRUNING, J. H., Bruggeman, C. A., Lautenschlager, I. T., & Häyry, P. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116622 · Cited by 149
Libby, P., Salomon, R., Payne, D. D., Schöen, F. J., & Pober, J. S. (1989) · PubMed · Cited by 141
Vieira, J., Schall, T. J., Corey, L., & Geballe, A. P. (1998) · Journal of Virology · doi:10.1128/jvi.72.10.8158-8165.1998 · Cited by 137
Xiao, C., Lachance, B., Sunahara, G. I., & Luong, J. H. T. (2002) · Analytical Chemistry · doi:10.1021/ac011104a · Cited by 134
Guidolin, D., Vacca, A., Nussdorfer, G. G., & Ribatti, D. (2003) · Microvascular Research · doi:10.1016/j.mvr.2003.11.002 · Cited by 128
Choroidal neovascularization: a wound healing perspective.
Kent, D. L., & Sheridan, C. (2003) · PubMed · Cited by 125
Lemström, K., Koskinen, P., Krogerus, L. A., Daemen, M. J. A. P., Bruggeman, C. A., & Häyry, P. (1995) · Circulation · doi:10.1161/01.cir.92.9.2594 · Cited by 108
Zhou, Y. F., Yu, Z., Wanishsawad, C., Shou, M., & Epstein, S. E. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.0387 · Cited by 105
Demonstration of cytomegalovirus nucleic acids in the coronary arteries of transplanted hearts.
Wu, T. ‐., Hruban, R. H., Ambinder, R. F., Pizzorno, M. C., Cameron, D. E., Baumgartner, W. A., Reitz, B. A., Hayward, G. S., & Hutchins, G. M. (1992) · PubMed Central · Cited by 98
Human cytomegalovirus alters interleukin-6 production by endothelial cells
Almeida, G., Porada, C., Jeor, S. S., & da Ascensão, J. L. (1994) · Blood · doi:10.1182/blood.v83.2.370.370 · Cited by 96
Humar, A., Louis, P. S., Mazzulli, T., McGeer, A., Lipton, J. H., Messner, H. A., & MacDonald, K. S. (1999) · The Journal of Infectious Diseases · doi:10.1086/314602 · Cited by 94
T-Cell Immunity to Subclinical Cytomegalovirus Infection Reduces Cardiac Allograft Disease
Tu, W., Potena, L., Stepick‐Biek, P., Liu, L., Dionis, K. Y., Luikart, H. I., Fearon, W. F., Holmes, T. H., Chin, C. C., Cooke, J. P., et al. (2006) · Circulation · doi:10.1161/circulationaha.105.607549 · Cited by 92
Khurana, R., & Simons, M. (2003) · Trends in Cardiovascular Medicine · doi:10.1016/s1050-1738(02)00259-1 · Cited by 91
Streblow, D. N., Kreklywich, C. N., Yin, Q., Melena, V. T. D. L., Corless, C. L., Smith, P. A., Brakebill, C., Cook, J. W., Vink, C., Bruggeman, C. A., et al. (2003) · Journal of Virology · doi:10.1128/jvi.77.3.2182-2194.2003 · Cited by 86
Self-citationBurns, L. J., Pooley, J. C., Walsh, D. J., Vercellotti, G. M., Weber, M. L., & Kovacs, A. (1999) · Transplantation · doi:10.1097/00007890-199901150-00023 · Cited by 86
Noda, S., Aguirre, S. A., BitMansour, A., Brown, J. W., Sparer, T. E., Huang, J., & Mocarski, E. S. (2005) · Blood · doi:10.1182/blood-2005-05-1833 · Cited by 81
Opportunistic infections after blood and marrow transplantation
Wingard, J. R. (1999) · Transplant Infectious Disease · doi:10.1034/j.1399-3062.1999.10102.x · Cited by 77
de Otero, J., Gavaldà, J., Murio, E., Vargas, V., Calicó, I., Llopart, L., Rosselló-Urgell, J., Margarit, C., & Pahissa, A. (1998) · Clinical Infectious Diseases · doi:10.1086/513949 · Cited by 69
Streblow, D. N., Kreklywich, C. N., Smith, P. P., Soule, J. L., Meyer, C., Yin, M. T., Beisser, P. S., Vink, C., Nelson, J. A., & Orloff, S. L. (2005) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2004.00711.x · Cited by 59
Self-citationShahgasempour, S., Woodroffe, S. B., & Garnett, H. M. (1997) · Microbiology and Immunology · doi:10.1111/j.1348-0421.1997.tb01177.x · Cited by 57
Reinhardt, B., Mertens, T., Mayr-Beyrle, U., FRANK, H., Lüske, A., Schierling, K., & Waltenberger, J. L. (2005) · Cardiovascular Research · doi:10.1016/j.cardiores.2005.03.012 · Cited by 57
ADAM-15 inhibits wound healing in human intestinal epithelial cell monolayers
Charrier, L., Yan, Y., Driss, A., LABOISSE, C. L., Sitaraman, S. V., & Merlin, D. (2004) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00262.2004 · Cited by 56
Shibata, M., Suzuki, H., Nakatani, M., Koba, S., Geshi, E., Katagiri, T., & Takeyama, Y. (2001) · Histochemistry and Cell Biology · doi:10.1007/s00418-001-0336-4 · Cited by 55
Helanterä, I., Loginov, R. J., Koskinen, P., Törnroth, T., Grönhagen‐Riska, C., & Lautenschlager, I. T. (2005) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfh714 · Cited by 43
Orloff, S. L., Streblow, D. N., Söderberg‐Nauclér, C., Yin, Q., Kreklywich, C. N., Corless, C. L., Smith, P. A., Loomis, C. B., Mills, L. K., Cook, J. W., et al. (2002) · Transplantation · doi:10.1097/00007890-200203150-00005 · Cited by 42
Self-citationCharacterization of monoclonal antibodies that define rat T cell alloantigens.
Ely, J. M., Greiner, D. L., Lubaroff, D. M., & Fitch, F. W. (1983) · The Journal of Immunology · doi:10.4049/jimmunol.130.6.2798 · Cited by 41
Vliegen, I., Duijvestijn, A. M., Stassen, F. R. M., & Bruggeman, C. A. (2004) · Microbes and Infection · doi:10.1016/j.micinf.2004.05.020 · Cited by 40
Tikkanen, J., Kallio, E. A., Bruggeman, C. A., KOSKINEN, P. K., & Lemström, K. (2001) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.164.4.2008058 · Cited by 39
BRUNING, J. H., Persoons, M. C. J., Lemström, K., Stals, F. S., Clercq, E. D., Bruggeman, C. A., BRUNING, J. H., Persoons, M. C. J., Stals, F. S., & Bruggeman, C. A. (1994) · Transplant International · doi:10.1111/j.1432-2277.1994.tb01393.x · Cited by 38
Orloff, S. L., Yin, Q., Corless, C. L., Orloff, M. S., Rabkin, J. M., & Wagner, C. R. (2000) · Transplantation · doi:10.1097/00007890-200004150-00015 · Cited by 33
Self-citationReinhardt, B., Winkler, M., Schaarschmidt, P., Pretsch, R., Zhou, S., Vaida, B., Schmid‐Kotsas, A., Michel, D., Walther, P., Bachem, M. G., et al. (2006) · Journal of General Virology · doi:10.1099/vir.0.81955-0 · Cited by 31
Mechanistic Study of Malononitrileamide FK778 in Cardiac Transplantation and CMV Infection in Rats
Zeng, H., Waldman, W. J., Yin, D., Knight, D. A., Shen, J., Ma, L., Meister, G. T., Chong, A. S., & Williams, J. W. (2004) · Transplantation · doi:10.1097/01.tp.0000137334.46155.94 · Cited by 31
Streblow, D. N., van Cleef, K. W. R., Kreklywich, C. N., Meyer, C., Smith, P. P., DeFilippis, V. R., Grey, F. E., Früh, K., Searles, R. P., Bruggeman, C. A., et al. (2007) · Journal of Virology · doi:10.1128/jvi.02425-06 · Cited by 28
Self-citationUpregulation of functionally active vascular endothelial growth factor by human cytomegalovirus
Reinhardt, B., Schaarschmidt, P., Bossert, A. S., Lüske, A., Finkenzeller, G., Mertens, T., & Michel, D. (2004) · Journal of General Virology · doi:10.1099/vir.0.80327-0 · Cited by 27
Importance of CMV in the transplant population.
Rubin, R. H. (1999) · PubMed · Cited by 25
Inkinen, K. A., Soots, A. P., Krogerus, L. A., Loginov, R. J., Bruggeman, C. A., & Lautenschlager, I. T. (2005) · Transplant International · doi:10.1111/j.1432-2277.2005.00113.x · Cited by 25
Helanterä, I., Teppo, A., Koskinen, P., Törnroth, T., Grönhagen‐Riska, C., & Lautenschlager, I. T. (2005) · Transplant Immunology · doi:10.1016/j.trim.2005.11.001 · Cited by 24
Fitzgerald, J. T., Gallay, B. J., Taranto, S. E., McVicar, J. P., Troppmann, C., Chen, X., McIntosh, M. J., & Perez, R. V. (2004) · Transplantation · doi:10.1097/01.tp.0000122184.97674.20 · Cited by 24
Almeida-Porada, G. D., Porada, C. D., Jd, S., & Ascensao, J. (1997) · PubMed · Cited by 22
Soule, J. L., Streblow, D. N., Andoh, T. F., Kreklywich, C. N., & Orloff, S. L. (2006) · Transplantation Proceedings · doi:10.1016/j.transproceed.2006.10.187 · Cited by 17
Self-citationSparer, T. E., Gosling, J., Schall, T. J., & Mocarski, E. S. (2004) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2004.24.611 · Cited by 16
Orloff, S. L. (1999) · Journal of Clinical Virology · doi:10.1016/s1386-6532(99)90486-9 · Cited by 12
Self-citationInkinen, K. A., Holma, K., Soots, A. P., Krogerus, L. A., Loginov, R. J., Bruggeman, C. A., Ahonen, J., & Lautenschlager, I. T. (2003) · Transplantation Proceedings · doi:10.1016/s0041-1345(03)00078-2 · Cited by 12
Schaarschmidt, P., Reinhardt, B., Michel, D., Vaida, B., Mayr, K., Lüske, A., Baur, R., Gschwend, J., KLEINSCHMIDT, K., Kountidis, M., et al. (1999) · Intervirology · doi:10.1159/000053972 · Cited by 10
Tikkanen, J., Kallio, E.-L., Pulkkinen, V., Bruggeman, C. A., Koskinen, P., & Lemström, K. (2001) · Transplantation Proceedings · doi:10.1016/s0041-1345(00)02686-5 · Cited by 7
Dm, L., Gt, R., & Hd, H. (1989) · PubMed · Cited by 5
RT1.C and rat bone marrow transplantation.
Klempnauer, J., & Marquarding, E. (1989) · PubMed · Cited by 3
Research works printed but not linked: 1
- Melnick JL, Adam E, DeBakey ME (1998) The link between CMV and atherosclerosis. Infect Med 15:479–486.
Cited by
Sorted by citations
Cytomegalovirus Latency and Reactivation: An Intricate Interplay With the Host Immune Response
Forte, E., Zhang, Z., Thorp, E. B., & Hummel, M. (2020) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2020.00130 · Cited by 284
Cytomegalovirus infection is associated with increased mortality in the older population
Savva, G. M., Pachnio, A., Kaul, B., Morgan, K., Huppert, F. A., Brayne, C., & Moss, P. A. H. (2013) · Aging Cell · doi:10.1111/acel.12059 · Cited by 216
Yu, Y., Clippinger, A. J., & Alwine, J. C. (2011) · Trends in Microbiology · doi:10.1016/j.tim.2011.04.002 · Cited by 199
The Immune Response to Human CMV
Rosa, C. L., & Diamond, D. J. (2012) · Future Virology · doi:10.2217/fvl.12.8 · Cited by 190
van de Berg, P. J., Heutinck, K. M., Raabe, R., Minnee, R. C., Young, S. L., der Pant, K. A. M. I. V. D., Bemelman, F. J., van Lier, R. A. W., & ten Berge, I. J. M. (2010) · The Journal of Infectious Diseases · doi:10.1086/655472 · Cited by 182
Metadata
- Authors
- Streblow, D. N., Dumortier, J., Moses, A. V., Orloff, S. L., & Nelson, J. A.
- Affiliations
- Oregon Health & Science University (US)
- Corresponding author
- Streblow, D. N.
- Venue
- Current Topics in Microbiology and Immunology
- Publisher
- Springer Berlin Heidelberg
- Published
- 2008
- Volume
- 325
- Pages
- 397-415
- ISSN
- 0070-217X (ISSN-L)
- PMC
- PMC2699259
- OpenAlex
- W125742586
- Cited by
- 125
- References
- 65
- Citations by year
- 2026: 2 · 2025: 1 · 2024: 3 · 2023: 2 · 2022: 3 · 2021: 5 · 2020: 3 · 2019: 3 · 2018: 6 · 2017: 4 · 2016: 8 · 2015: 6 · 2014: 10 · 2013: 11 · 2012: 15
- FWCI
- 38.67
- Type
- book chapter
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Current topics in microbiology and immunology (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- U.S. Department of Veterans Affairs
- American Heart Association
- National Institutes of Health
- National Heart, Lung, and Blood Institute (HL 66238-01, R01HL083194, R01HL071695, HL 083194, R01HL065754, HL65754, R01HL085451, HL71695, R01HL066238, R01HL088603)
- National Institute of Allergy and Infectious Diseases (AI21640, R37AI021640, R01AI021640)
- Topics
- Health Sciences › Medicine › Epidemiology › Cytomegalovirus and herpesvirus research
- Health Sciences › Medicine › Surgery › Transplantation: Methods and Outcomes
- Health Sciences › Medicine › Oncology › Viral-associated cancers and disorders
- Keywords
- human cytomegalovirus, vascular disease, chronic rejection, angiogenesis, wound healing, paracrine signaling, secretome, cytokines and growth factors, rat cytomegalovirus, atherosclerosis, restenosis, smooth muscle cell proliferation, ganciclovir
- MeSH terms
- Animals, Cytomegalovirus Infections, Cytomegalovirus, Humans, Sclerosis, Vascular Diseases, Cytokines, Intercellular Signaling Peptides and Proteins, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review